Finance

Latest News

Amylyx Pharmaceuticals Acquires Phase III-Ready GLP-1 Receptor Agonist Avexitide for Hyperinsulinemic Hypoglycemia from Eiger BioPharmaceuticals
Amylyx Pharmaceuticals Acquires Phase III-Ready GLP-1 Receptor Agonist Avexitide for Hyperinsulinemic Hypoglycemia from Eiger BioPharmaceuticals

July 12th 2024

Avexitide has received Breakthrough Therapy Designation by the FDA for post-bariatric hypoglycemia, congenital hyperinsulinism, and more.

Johnson & Johnson Inks Deal to Acquire Yellow Jersey Therapeutics in $1.25 Billion All-Cash Deal
Johnson & Johnson Inks Deal to Acquire Yellow Jersey Therapeutics in $1.25 Billion All-Cash Deal

July 11th 2024

Eli Lilly Strikes Deal to Acquire Morphic for $3.2 Billion
Eli Lilly Strikes Deal to Acquire Morphic for $3.2 Billion

July 9th 2024

Moderna Awarded $176 Million from the Biomedical Advanced Research and Development Authority to Expedite Development of mRNA-Based Influenza Vaccines
Moderna Awarded $176 Million from the Biomedical Advanced Research and Development Authority to Expedite Development of mRNA-Based Influenza Vaccines

July 3rd 2024

Eli Lilly, OpenAI Strike Collaboration Agreement Seeking to Discover New Antimicrobials to Fight Drug-Resistant Bacteria
Eli Lilly, OpenAI Strike Collaboration Agreement Seeking to Discover New Antimicrobials to Fight Drug-Resistant Bacteria

June 26th 2024

More News